AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionAmerican Money Management, LLC
Latest Disclosed Ownership43,748 shares
Latest Disclosed Value $ 9,514,804
American Money Management, LLC reports 0.55% decrease in ownership of ABBV / AbbVie Inc.

On May 11, 2026 - American Money Management, LLC filed a 13F-HR form disclosing ownership of 43,748 shares of AbbVie Inc. (MX:ABBV) valued at $9,514,804 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 43,989 shares of AbbVie Inc.. This represents a change in shares of -0.55% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AbbVie Inc Com COM 00287Y109 43,748 -241 -0.55 9,515 -5.34 1.5057
2026-02-10 2025-12-31 13F AbbVie Inc Com COM 00287Y109 43,989 2,778 6.74 10,051 5.35 1.5797
2025-11-10 2025-09-30 13F AbbVie Inc Com COM 00287Y109 41,211 340 0.83 9,542 25.77 1.5922
2025-08-13 2025-06-30 13F AbbVie Inc Com COM 00287Y109 40,871 -24 -0.06 7,586 -11.46 1.3409
2025-05-13 2025-03-31 13F AbbVie Inc Com COM 00287Y109 40,895 -128 -0.31 8,568 17.55 1.6251
2025-02-12 2024-12-31 13F AbbVie Inc Com COM 00287Y109 41,023 284 0.70 7,290 -9.40 1.4222
2024-11-12 2024-09-30 13F AbbVie Inc Com COM 00287Y109 40,739 -387 -0.94 8,045 14.06 1.6081
2024-08-13 2024-06-30 13F AbbVie Inc Com COM 00287Y109 41,126 -116 -0.28 7,054 -6.09 1.5058
2024-05-09 2024-03-31 13F AbbVie Inc Com COM 00287Y109 41,242 -214 -0.52 7,510 16.91 1.5664
2024-02-13 2023-12-31 13F AbbVie Inc Com COM 00287Y109 41,456 553 1.35 6,424 5.36 1.4480
2023-11-13 2023-09-30 13F AbbVie Inc Com COM 00287Y109 40,903 2,072 5.34 6,097 16.56 1.5578
2023-08-08 2023-06-30 13F AbbVie Inc Com COM 00287Y109 38,831 -34 -0.09 5,232 -15.53 1.3049
2023-05-10 2023-03-31 13F AbbVie Inc Com COM 00287Y109 38,865 -904 -2.27 6,194 -3.64 1.6450
2023-02-10 2022-12-31 13F AbbVie Inc Com COM 00287Y109 39,769 80 0.20 6,427 20.65 1.8325
2022-11-10 2022-09-30 13F AbbVie Inc Com COM 00287Y109 39,689 700 1.80 5,327 -10.80 1.6248
2022-08-02 2022-06-30 13F AbbVie Inc Com COM 00287Y109 38,989 -7,720 -16.53 5,972 -21.13 1.7389
2022-05-12 2022-03-31 13F AbbVie Inc Com COM 00287Y109 46,709 -341 -0.72 7,572 18.85 2.0126
2022-02-11 2021-12-31 13F AbbVie Inc Com COM 00287Y109 47,050 89 0.19 6,371 25.76 1.6533
2021-11-12 2021-09-30 13F AbbVie Inc Com COM 00287Y109 46,961 4,253 9.96 5,066 5.30 1.4322
2021-08-10 2021-06-30 13F AbbVie Inc Com COM 00287Y109 42,708 8 0.02 4,811 4.11 1.6290
2021-05-12 2021-03-31 13F AbbVie Inc Com COM 00287Y109 42,700 -416 -0.96 4,621 0.02 1.7208
2021-02-10 2020-12-31 13F AbbVie Inc Com COM 00287Y109 43,116 475 1.11 4,620 23.69 1.8072
2020-11-12 2020-09-30 13F AbbVie Inc Com COM 00287Y109 42,641 1,058 2.54 3,735 -8.12 1.6927
2020-08-13 2020-06-30 13F AbbVie Inc Com COM 00287Y109 41,583 -352 -0.84 4,065 27.23 1.8963
2020-05-13 2020-03-31 13F AbbVie Inc Com COM 00287Y109 41,935 406 0.98 3,195 -13.11 1.7893
2020-02-12 2019-12-31 13F AbbVie Inc Com COM 00287Y109 41,529 -234 -0.56 3,677 16.29 1.7172
2019-11-14 2019-09-30 13F AbbVie Inc Com COM 00287Y109 41,763 -2,546 -5.75 3,162 -1.86 1.6879
2019-08-12 2019-06-30 13F AbbVie Inc Com COM 00287Y109 44,309 1,832 4.31 3,222 -5.87 1.7216
2019-05-08 2019-03-31 13F AbbVie Inc Com COM 00287Y109 42,477 -542 -1.26 3,423 -13.69 1.9031
2019-02-12 2018-12-31 13F AbbVie Inc Com COM 00287Y109 43,019 -179 -0.41 3,966 -2.94 2.5004
2018-11-14 2018-09-30 13F AbbVie Inc Com COM 00287Y109 43,198 2,019 4.90 4,086 7.10 2.3405
2018-08-10 2018-06-30 13F AbbVie Inc Com COM 00287Y109 41,179 -607 -1.45 3,815 -3.54 2.3114
2018-05-11 2018-03-31 13F AbbVie Inc Com COM 00287Y109 41,786 -2,577 -5.81 3,955 -7.81 2.4692
2018-02-13 2017-12-31 13F AbbVie Inc Com COM 00287Y109 44,363 -503 -1.12 4,290 7.60 2.6003
2017-11-13 2017-09-30 13F AbbVie Inc Com COM 00287Y109 44,866 -291 -0.64 3,987 21.78 2.6500
2017-08-14 2017-06-30 13F AbbVie Inc Com COM 00287Y109 45,157 -413 -0.91 3,274 10.27 2.3292
2017-05-11 2017-03-31 13F AbbVie Inc Com COM 00287Y109 45,570 3,217 7.60 2,969 11.95 2.1912
2017-02-14 2016-12-31 13F AbbVie Inc Com COM 00287Y109 42,353 -911 -2.11 2,652 -2.82 2.1331
2016-11-14 2016-09-30 13F AbbVie Inc Com COM 00287Y109 43,264 535 1.25 2,729 3.18 2.1810
2016-08-11 2016-06-30 13F AbbVie Inc Com COM 00287Y109 42,729 -874 -2.00 2,645 6.18 2.1883
2016-05-12 2016-03-31 13F AbbVie Inc Com COM 00287Y109 43,603 6,035 16.06 2,491 11.90 2.0633
2016-02-11 2015-12-31 13F AbbVie Inc Com COM 00287Y109 37,568 2,615 7.48 2,226 17.03 1.9094
2015-11-12 2015-09-30 13F AbbVie Inc Com COM 00287Y109 34,953 -3,139 -8.24 1,902 -25.67 1.7971
2015-08-12 2015-06-30 13F AbbVie Inc Com COM 00287Y109 38,092 -499 -1.29 2,559 13.28 2.1633
2015-05-15 2015-03-31 13F AbbVie Inc Com COM 00287Y109 38,591 8,127 26.68 2,259 13.29 1.9737
2015-02-10 2014-12-31 13F AbbVie Inc Com COM 00287Y109 30,464 -6,254 -17.03 1,994 -5.94 1.7187
2014-11-12 2014-09-30 13F AbbVie Inc Com COM 00287Y109 36,718 -980 -2.60 2,121 -0.38 1.7973
2014-08-07 2014-06-30 13F AbbVie Inc Com COM 00287Y109 37,698 70 0.19 2,128 10.03 1.7412
2014-05-07 2014-03-31 13F AbbVie Inc Com COM 00287Y109 37,628 4,673 14.18 1,934 11.15 1.6438
2014-02-14 2013-12-31 13F AbbVie Inc Com COM 00287Y109 32,955 32,955 1,740 1.4995
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.